Urinary Tract Infections: Etiology and Treatment

Introduction to Urinary Tract Infections

The American College of Radiology and European Urology guidelines suggest that E. coli and Proteus mirabilis are common causes of urinary tract infections (UTIs), with E. coli being the most common (approximately 75-80% of UTIs) 1, 2
The European Urology guidelines indicate that Proteus mirabilis is one of the most common secondary pathogens after E. coli and Enterococcus faecalis, especially in complicated UTIs 3, 1
Both organisms colonize the perineal area and ascend through the urethra to the bladder, particularly facilitated by sexual activity, catheter use, or anatomical anomalies 1, 2

The American College of Radiology and European Urology guidelines recommend nitrofurantoin, fosfomycin, or trimethoprim-sulfamethoxazole (if local resistance is <20%) as the first-line treatment for uncomplicated cystitis 4
The European Urology guidelines suggest that fluoroquinolones should be reserved as a second-line treatment due to increasing resistance 4

The European Urology guidelines recommend ciprofloxacin 500-750 mg twice daily for 7 days as the treatment of choice if local resistance to fluoroquinolones is <10% 3, 4
Alternative options include levofloxacin 750 mg once daily for 5 days (if resistance <10%) 3 and trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days (if susceptibility is confirmed) 3, 4

The European Urology guidelines state that the management of complicated UTIs requires mandatory urine culture, initial empirical treatment based on local resistance patterns, and a duration of 7-14 days (14 days in men when prostatitis cannot be excluded) 3
The guidelines also recommend that the underlying urological abnormality or complicating factor must be appropriately managed 3

The European Urology guidelines indicate that Proteus mirabilis is a urease-producing bacterium that can cause urinary stone formation, requiring exclusion of lithiasis if there is persistent growth 5, 2

The European Urology guidelines list the following factors as classifying a UTI as complicated and requiring more aggressive management: obstruction at any site in the urinary tract, pregnancy 1, diabetes mellitus 1, and infections associated with healthcare 4

The American Urological Association recommends amoxicillin-clavulanate as a suitable option for outpatient management of P. mirabilis UTIs, given the organism's susceptibility 6
The Infectious Diseases Society of America suggests piperacillin-tazobactam as a broader-spectrum option for hospitalization 6

The European Association of Urology recommends imaging to exclude urolithiasis in patients with P. mirabilis UTIs, as the organism is a urease-producing bacterium that can catalyze struvite stone formation 7
Clinical cure should occur within 3-7 days; persistent symptoms beyond 7 days warrant repeat culture, according to the American College of Physicians 7

The International Society for Chemotherapy recommends against routine repeat urine culture after successful symptom resolution, as this may lead to overtreatment of asymptomatic bacteriuria 7
Repeat culture is indicated if symptoms persist beyond 7 days of appropriate therapy, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 7

The American College of Obstetricians and Gynecologists recommends urological evaluation for anatomical abnormalities or stones in patients with recurrent P. mirabilis infections 7
The Infectious Diseases Society of America suggests avoiding nitrofurantoin for complicated UTIs, despite it being first-line for uncomplicated cystitis, due to poor tissue penetration and potential resistance, as reported in Clinical Microbiology and Infection 8